Chlorhexidine Gluconate Product for Patient Skin Antisepsis Research:CAGR of 3.6% during the forecast period

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2024 latest report "Chlorhexidine Gluconate Product for Patient Skin Antisepsis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030". Based on current situation and impact historical analysis (2019-2023) and forecast calculations (2024-2030), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.



The global market for Chlorhexidine Gluconate Product for Patient Skin Antisepsis was estimated to be worth US$ 610 million in 2023 and is forecast to a readjusted size of US$ 885 million by 2030 with a CAGR of 5.8% during the forecast period 2024-2030.



【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】

https://www.qyresearch.com/reports/3274742/chlorhexidine-gluconate-product-for-patient-skin-antisepsis





Chlorhexidine Gluconate Product for Patient Skin Antisepsis Definition

Chlorhexidine Gluconate (CHG) products for patient skin antisepsis are medical-grade antiseptic Wash Lotion & Solution, Wipes, Gloves, Caps, etc. specifically to disinfect and cleanse the skin, thereby reducing the presence of harmful microorganisms. These products are widely used in healthcare settings for various purposes, including preoperative skin preparation and routine patient hygiene.





Chlorhexidine Gluconate Product for Patient Skin Antisepsis Industry View

Chlorhexidine gluconate (CHG) products are specially formulated for disinfection and cleaning of the skin, which can effectively reduce the presence of harmful microorganisms. They are widely used for preoperative skin preparation and routine patient hygiene. Common product types include solutions, washes, wipes, shampoo caps, brushes, applicators, etc.

Chlorhexidine gluconate has a killing effect on Gram-positive and Gram-negative bacteria, facultative anaerobes, aerobic bacteria and yeasts. It is particularly effective against Gram-positive bacteria. With the advent of an aging population, the number of surgeries worldwide has increased year by year. According to statistics, more than 300 million people undergo surgical operations worldwide each year, and surgical site infections (SSIs) and the wounds they cause are also increasing. It refers to nosocomial infections secondary to surgery that occur at or near the surgical incision, deep organs or cavities. It is one of the serious complications after modern surgery and orthopedics, a common cause of unplanned readmissions, and a global problem. SSI patients account for 2% to 5% of hospitalized surgical patients, and the annual incidence rate varies. The number of SSI patients in the United States is 160,000 to 300,000 per year. Studies have shown that chlorhexidine is more advantageous than povidone-iodine in preventing total infection and superficial site infection after potentially contaminated surgery.

With the outbreak of COVID-19, chlorhexidine gluconate ushered in explosive growth in 2020-2021. From a global perspective, Europe and the United States are the core market areas for chlorhexidine gluconate (CHG) products, especially North America, which accounts for 43% of the revenue share, followed by Europe, which accounts for 35% of the market share. The Asia-Pacific region currently mainly uses povidone-iodine for preoperative skin disinfection, but with the continuous expansion of awareness of chlorhexidine gluconate products and the gradual deepening of market promotion, there will be huge market potential in the future.

There are many global players in the chlorhexidine gluconate market, with a wide variety of product types, but most of them are small in scale. The top five manufacturers are mainly European and American companies, namely BD, Ecolab, Stryker, Molnlycke, and Xttrium, which will account for more than 60% of the global market share in 2023. Among them, BD's ChloraPrep applicator products are the world's leading sales, with annual sales exceeding 150 million units. Product types have also gradually evolved from the initial solutions and lotions to wet wipes, gloves, brushes, shampoo caps, etc. Currently, lotions and solution products occupy the core market share.

Chlorhexidine gluconate products are widely used for patient skin disinfection to prevent infection, including hospital-acquired infections (HAIs) and surgical site infections (SSIs). With the increase in demand in surgical and preoperative environments and the increasing awareness of infection prevention, the overall market will continue to expand.



Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Summary

According to the new market research report "Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Report 2024-2030", published by QYResearch, the global Chlorhexidine Gluconate Product for Patient Skin Antisepsis market size is projected to reach USD 0.78 billion by 2030, at a CAGR of 3.6% during the forecast period.

Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis MarketSize(US$ Million), 2019-2030
241204-171818.webp (26 KB)

Above data is based on report from QYResearch: Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Report 2024-2030 (published in 2024). If you need the latest data, plaese contact QYResearch.



Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Top20 Players Rankingand Market Share (Ranking is based on the revenue of 2023, continually updated)
241204-171849.webp (35 KB)

Above data is based on report from QYResearch: Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Report 2024-2030 (published in 2024). If you need the latest data, plaese contact QYResearch.

According to QYResearch Top Players Research Center, the global key manufacturers of Chlorhexidine Gluconate Product for Patient Skin Antisepsis include BD, Ecolab, Stryker, Molnlycke, Xttrium, 3M, B. Braun, Medichem, GAMA Healthcare, PDI EMEA Ltd., etc. In 2023, the global top five players had a share approximately 60.0% in terms of revenue.

Chlorhexidine Gluconate Product for Patient Skin Antisepsis,Global Market Size, Split by Product Segment
241204-171908.webp (30 KB)

Based on or includes research from QYResearch: Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Report 2024-2030.

In terms of product type, currently Antiseptic Wash Lotion & Solution is the largest segment, hold a share of 54.6%.

In terms of product application, currently Intensive Care Unit is the largest segment, hold a share of 38.82%.





The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.



The Chlorhexidine Gluconate Product for Patient Skin Antisepsis market is segmented as below:

By Company

BD
Ecolab
Stryker
Molnlycke
Xttrium
3M
B. Braun
Medichem
GAMA Healthcare
PDI EMEA Ltd.
Arion Deutschland GmbH
Medline
CV Médica
Bajaj Medical LLC
SC Johnson Professional
Germo
ACTO GmbH
Lernapharm (LORIS)
URGO Sp. z o.o.
Welcare Industries
Pearmine Health (Dymacare)
Valderma
Innopart Medpro
Raman & Weil Science
Microwin Labs
Weigao Group
Lionser
ShanDong Mint Medical Technology
KINGFA MEDICAL
Shandong Retouch Wash and Sterilize Technology
Liaoning Control Sensory Disinfection Technology
Shandong Disineer Disinfection Science and Technology



Segment by Type

Antiseptic Wash Lotion & Solution
Antiseptic Wipes & Gloves
Antiseptic Caps
Others



Segment by Application

Operating Theatre
Intensive Care Unit
General Ward
Others



Each chapter of the report provides detailed information for readers to further understand the Chlorhexidine Gluconate Product for Patient Skin Antisepsis market:

Chapter 1: Introduces the report scope of the Chlorhexidine Gluconate Product for Patient Skin Antisepsis report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2019-2030)

Chapter 2: Detailed analysis of Chlorhexidine Gluconate Product for Patient Skin Antisepsis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2019-2024)

Chapter 3: Provides the analysis of various Chlorhexidine Gluconate Product for Patient Skin Antisepsis market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2019-2030)

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2019-2030)

Chapter 5: Sales, revenue of Chlorhexidine Gluconate Product for Patient Skin Antisepsis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2019-2030)

Chapter 6: Sales, revenue of Chlorhexidine Gluconate Product for Patient Skin Antisepsis in country level. It provides sigmate data by Type, and by Application for each country/region.(2019-2030)

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2019-2024)

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.



Benefits of purchasing QYResearch report:

Competitive Analysis: QYResearch provides in-depth Chlorhexidine Gluconate Product for Patient Skin Antisepsis competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.

Industry Analysis: QYResearch provides Chlorhexidine Gluconate Product for Patient Skin Antisepsis comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.

and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.

Market Size: QYResearch provides Chlorhexidine Gluconate Product for Patient Skin Antisepsis market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.



Other relevant reports of QYResearch:

Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Research Report 2024
Global and United States Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Report & Forecast 2024-2030
Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Insights, Forecast to 2030
Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Report, History and Forecast 2019-2030

About Us：

QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 17 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)  
JP: https://www.qyresearch.co.jp

This release was published on openPR.